comparemela.com

Latest Breaking News On - Amphastar pharmaceuticals daily - Page 11 : comparemela.com

Amphastar Pharmaceuticals (NASDAQ:AMPH) Rating Increased to Buy at StockNews com

StockNews.com upgraded shares of Amphastar Pharmaceuticals (NASDAQ:AMPH – Free Report) from a hold rating to a buy rating in a research note issued to investors on Thursday morning. A number of other equities research analysts have also weighed in on AMPH. Piper Sandler raised their price objective on Amphastar Pharmaceuticals from $66.00 to $71.00 in […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.